
OLD Category: immuno-oncology
December 19, 2019 / JCI Insight
Neutrophil content predicts lymphocyte depletion and anti-PD1 treatment failure in NSCLC
December 19, 2019 / Blood
EBV-microRNA-BHRF1-2-5p targets the 3’UTR of immune-checkpoint ligands PD-L1 and PD-L2
December 17, 2019 / Cancer Res
HPV16 E5 Mediates Resistance to PD-L1 Blockade and can be targeted with Rimantadine in Head and Neck Cancer
December 12, 2019 / JCI Insight
Immunologic alterations in the pancreatic cancer microenvironment of patients treated with neoadjuvant chemo- and radiotherapy
December 5, 2019 / Nat Commun
Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4
December 3, 2019 / Nat Commun
An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment
December 2, 2019 / J Clin Invest
β2 adrenergic receptor–mediated signaling regulates the immunosuppressive potential of myeloid-derived suppressor cells
December 1, 2019 / Monoclon Antib Immunodiagn Immunother
Characterization of a Novel Bispecific Antibody That Activates T Cells In Vitro and Slows Tumor Growth In Vivo
November 22, 2019 / J Pathol.